BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36811792)

  • 1. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
    Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
    Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
    Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
    Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
    Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
    Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
    Tauziède-Espariat A; Uro-Coste E; Sievers P; Nicaise Y; Mariet C; Siegfried A; Pierron G; Guillemot D; Benzakoun J; Pallud J; Roques M; Bonneville F; Larrieu-Ciron D; Chaynes P; Saffroy R; Hamelin J; Hasty L; Métais A; Chrétien F; Kool M; Gojo J; Varlet P;
    Acta Neuropathol Commun; 2023 Feb; 11(1):26. PubMed ID: 36782314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
    Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
    Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
    Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
    Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
    Tauziède-Espariat A; Pierron G; Siegfried A; Guillemot D; Uro-Coste E; Nicaise Y; Castel D; Catalaa I; Larrieu-Ciron D; Chaynes P; de Barros A; Nicolau J; Gareton A; Lechapt E; Chrétien F; Bourdeaut F; Doz F; Bouchoucha Y; Grill J; Beccaria K; Boddaert N; Saffroy R; Pagès M; Varlet P
    Acta Neuropathol Commun; 2020 Nov; 8(1):178. PubMed ID: 33138864
    [No Abstract]   [Full Text] [Related]  

  • 10. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
    Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
    Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
    De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
    Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
    Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
    World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.
    Nakata S; Arai Y; Fukuoka K; Shirakura T; Yamazaki A; Osawa S; Hama N; Shibata T; Miyagishima T; Horiguchi K; Tosaka M; Yokoo H; Yoshimoto Y; Nobusawa S
    Brain Tumor Pathol; 2024 Jan; 41(1):35-39. PubMed ID: 38133797
    [No Abstract]   [Full Text] [Related]  

  • 17. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
    Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
    Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
    Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2.
    Salgado CM; Zin A; Garrido M; Kletskaya I; DeVito R; Reyes-Múgica M; Bisogno G; Donofrio V; Alaggio R
    Pediatr Dev Pathol; 2020; 23(6):424-430. PubMed ID: 32790583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
    Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
    Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.